[Federal Register Volume 77, Number 10 (Tuesday, January 17, 2012)]
[Notices]
[Page 2353]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-710]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Research Advisory Committee on Gulf War Veterans' Illnesses; 
Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under Public 
Law 92-463 (Federal Advisory Committee Act) that the Research Advisory 
Committee on Gulf War Veterans' Illnesses will meet on January 31 and 
February 1, 2012. The meeting will be held in room 1143 of the 
Lafayette Building, 811 Vermont Avenue NW., Washington, DC. The meeting 
will start at 8 a.m. each day and will adjourn at 5 p.m. on January 31 
and at 12:30 p.m. on February 1. All sessions will be open to the 
public.
    The purpose of the Committee is to provide advice and make 
recommendations to the Secretary of Veterans Affairs on proposed 
research studies, research plans and research strategies relating to 
the health consequences of military service in the Southwest Asia 
theater of operations during the Gulf War.
    The Committee will review VA program activities related to Gulf War 
Veterans' illnesses and updates on relevant scientific research 
published since the last Committee meeting. The session on January 31 
will be devoted to discussion of the Gulf War Research Strategic Plan 
being prepared in VA's Office of Research and Development followed by 
an update of VA Gulf War research funding. The research presentations 
on February 1 will involve background information on Gulf War Veterans' 
illnesses, nervous system function, its relation to ill Gulf War 
Veterans, and possible laboratory markers for Gulf War Veterans' 
illnesses. The session will also include discussion of Committee 
business and activities.
    The meeting will include time reserved for public comments each 
day. A sign-up sheet for five-minute comments will be available at the 
meeting. Individuals who speak are invited to submit a 1-2 page summary 
of their comments at the time of the meeting for inclusion in the 
official meeting record. Members of the public may also submit written 
statements for the Committee's review to Dr. Roberta White at 
<a href="/cdn-cgi/l/email-protection#a7d5d0cfced3c2e7c5d289c2c3d2"><span class="__cf_email__" data-cfemail="f1838699988594b19384df949584">[email protected]</span></a>.
    Any member of the public seeking additional information should 
contact Dr. Roberta White, Scientific Director, at (617) 638-4620 or 
Dr. Victor Kalasinsky, Designated Federal Officer, at (202) 443-5682, 
or email at <a href="/cdn-cgi/l/email-protection#63150a00170c114d08020f02100a0d10081a2315024d040c15"><span class="__cf_email__" data-cfemail="4d3b242e39223f63262c212c3e24233e26340d3b2c632a223b">[email protected]</span></a>.

    Dated: January 11, 2012.

By direction of the Secretary.
Vivian Drake,
Committee Management Officer.
[FR Doc. 2012-710 Filed 1-13-12; 8:45 am]
BILLING CODE P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>